Treatment trends in human immunodeficiency virus disease. SymposiumVOLBERDING, PAUL A.The Journal of infectious diseases. 1995, Vol 171, issn 0022-1899, 80 p., SUP2Conference Proceedings

Biologic effects and safety of stavudine : overview of phase I and II clinical trialsSKOWRON, G.The Journal of infectious diseases. 1995, Vol 171, pp S113-S117, issn 0022-1899, SUP2Conference Paper

Clinical aspects of human immunodeficiency virus disease : clinical rationale for treatmentMURPHY, R.The Journal of infectious diseases. 1995, Vol 171, pp S81-S87, issn 0022-1899, SUP2Conference Paper

The need for additional options in the treatment of human immunodeficiency virus infectionVOLBERDING, P.The Journal of infectious diseases. 1995, Vol 171, pp S150-S154, issn 0022-1899, SUP2Conference Paper

Epoetin alfa for treatment of anemia in HIV-infected: Patients past, present, and futureHENRY, David H; VOLBERDING, Paul A; LEITZ, Gerhard et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 2, pp 1221-1227, issn 1525-4135, 7 p.Article

Do new protease inhibitors offer improved outcome expectations? Issues of PI adherenceSHERER, Renslow D; VOLBERDING, Paul A.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, pp 35-43, issn 1525-4135, 9 p., SUP1Conference Paper

Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2',3'-dideoxynucleoside analoguesSOMMADOSSI, J.-P.The Journal of infectious diseases. 1995, Vol 171, pp S88-S92, issn 0022-1899, SUP2Conference Paper

Antiretroviral therapy and management of HIV infectionVOLBERDING, Paul A; DEEKS, Steven G.Lancet (British edition). 2010, Vol 376, Num 9734, pp 49-62, issn 0140-6736, 14 p.Article

Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1JOHNSON, V. A.The Journal of infectious diseases. 1995, Vol 171, pp S140-S149, issn 0022-1899, SUP2Conference Paper

Opportunities and options for treatment research in resource-constrained settingsVOLBERDING, Paul A.Clinical infectious diseases. 2003, Vol 37, pp S1-S3, issn 1058-4838, SUP1Article

Clinical pharmacokinetics of nucleoside antiretroviral agentsDUDLEY, M. N.The Journal of infectious diseases. 1995, Vol 171, pp S99-S112, issn 0022-1899, SUP2Conference Paper

HIV therapy in 2003: consensus and controversyVOLBERDING, Paul A.AIDS (Supplement). 2003, Vol 17, pp S4-S11, issn 1350-2840, SUP1Article

Racial differences in end-stage renal disease rates in HIV infection versus diabetesCHOI, Andy I; RODRIGUEZ, Rudolph A; BACCHETTI, Peter et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 11, pp 2968-2974, issn 1046-6673, 7 p.Article

Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected PersonsCHOI, Andy I; YONGMEI LI; DEEKS, Steven G et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 5, pp 651-658, issn 0009-7322, 8 p.Article

The Pavia consensus statementVOLBERDING, Paul A; MURPHY, Robert L; GALLI, Massimo et al.AIDS (Supplement). 2003, Vol 17, pp S170-S179, issn 1350-2840, SUP1Article

Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA panelYENI, Patrick G; HAMMER, Scott M; MONTANER, Julio S. G et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 222-235, issn 0098-7484Article

Clinician Attitudes About Commercial Support of Continuing Medical Education: Results of a Detailed SurveyTABAS, Jeffrey A; BOSCARDIN, Christy; JACOBSEN, Donna M et al.Archives of internal medicine (1960). 2011, Vol 171, Num 9, pp 840-846, issn 0003-9926, 7 p.Article

Prevalence of Primary Resistance at Baseline in Acutely and Recently Infected Subjects Enrolled in AIDS Clinical Trials Group Protocol 371DYKES, Carrie; MUKHERJEE, A. Lisa; BOSCH, Ronald J et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 1, pp 132-134, issn 1525-4135, 3 p.Article

Antiretroviral Treatment of Adult HIV Infection : 2008 Recommendations of the International AIDS Society-USA PanelHAMMER, Scott M; ERON, Joseph J; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2008, Vol 300, Num 5, pp 555-570, issn 0098-7484, 16 p.Article

Antiretroviral Treatment of Adult HIV Infection: 2014 Recommendations of the International Antiviral Society-USA PanelGÜNTHARD, Huldrych F; ABERG, Judith A; REISS, Peter et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 4, pp 410-425, issn 0098-7484, 16 p.Article

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society―USA PanelTHOMPSON, Melanie A; ABERG, Judith A; RICHMAN, Douglas D et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 4, pp 387-402, issn 0098-7484, 16 p.Article

Hematologic Toxicity Associated with Interferon-Based Hepatitis C Therapy in HIV Type 1-Coinfected SubjectsBEHLER, Caroline M; VITTINGHOFF, Eric; FENG LIN et al.Clinical infectious diseases. 2007, Vol 44, Num 10, pp 1375-1383, issn 1058-4838, 9 p.Article

Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: Case report and 8-year follow-upMICHAELS, Marian G; KAUFMAN, Christina; ILDSTAD, Suzanne T et al.Transplantation. 2004, Vol 78, Num 11, pp 1582-1589, issn 0041-1337, 8 p.Article

Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA PanelTHOMPSON, Melanie A; ABERG, Judith A; JACOBSEN, Donna M et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 3, pp 321-333, issn 0098-7484, 13 p.Article

Low Rates of Antiretroviral Therapy among HIV-Infected Patients with Chronic Kidney DiseaseCHOI, Andy I; RODRIGUEZ, Rudolph A; BACCHETTI, Peter et al.Clinical infectious diseases. 2007, Vol 45, Num 12, pp 1633-1639, issn 1058-4838, 7 p.Article